Special coagulation tests are performed to measure the blood’s ability to clot and the time taken in it. The special coagulation tests are prescribed by the doctor in case of clotting disorders.
The coagulation disorders may be caused due to thrombophilia (condition of excessive clotting), hemophilia (Condition of inability to clot normally), blood factor deficiency, or other liver diseases.
The coagulation disorders may be either acquired or inherited. Coagulation is an innate process that prevents the excessive bleeding in case of a cut or skin injury.
The blood in the blood vessels should not clot, or hence will lead to severe conditions such as, stroke, heart attack or even death.
The special coagulation test measures the capability of the blood to form a clot in case of physical injury leading to blood loss.
The special coagulation laboratory tests are useful in elucidating the cause of excessive bleeding.
Moreover, the tests do not provide information concerning the occurrence of bleeding in post- operative or perioperative period.
Also, the well described special coagulation test, are used to detect the hereditary predilection of thrombosis. The coagulation disorders may be either acquired or inherited.
The increasing demand of special coagulation testing is projected to grow in the forecast period with the growing population base suffering from chronic blood disorders, cardiovascular disorders, and lifestyle associated diseases.
Moreover, the increasing awareness about these conditions is anticipated to improve the preventive care management and diagnostic rate, which is expected to substantially drive the global special coagulation test market.
In most of the under developed and developing countries, the less popularity of the procedure and high implementation cost are the factors responsible for restraining the growth of special coagulation test market.
The lack of skilled and trained professionals also hinders the growth of special coagulation test market.
Ask for Customization @
Special Coagulation Test Market: Overview
The special coagulation tests are beneficial for monitoring people, prescribed with medications that improve clotting ability.
The special coagulation tests are sometimes recommended before the surgical procedures. Excessive bleeding disorders can lead to abnormal bleeding, thereby increasing danger to the life.
The special coagulation tests are considered to be the most important, for the diagnosis and monitoring of the coagulation status.
Special Coagulation test involve different types of test, of which prothrombin time (PT) is widely used. Based on technology type, electrochemical technique is the most preferred technique.
On the basis of end user, the diagnostic laboratories segment is considered to be the major segment in the market of special coagulation test market.
Special Coagulation Test Market: Regional Overview
Geographically, the global Special coagulation test market is segmented into seven key regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.
North America followed by Western Europe hold the largest share of Special coagulation test market owing to the high adoption rates of the coagulation testing instruments such as POC testing PT monitors, analyzers, etc.
The increased awareness among the people about the importance and need of monitoring and detecting the coagulation status, increasing prevalence of cardiovascular diseases, and the availability of a favorable reimbursement scenario are the factors propelling the market of Special coagulation test in these regions.
The Special coagulation testing market in Asia Pacific and Middle Eastern Countries are at the initial level. It is projected that Asia Pacific region will experience a significant growth in the market share over the forecast period.
Ask Us Your Questions About This Report @
Special Coagulation Test Market: Key Players
The major key players in the global Special coagulation test market are F. Hoffmann-La Roche Ltd., Alere Inc., Abbott Laboratories, SYSMEX CORPORATION, Siemens Healthineers, HemoSonics, LLC, Universal Biosensors, Inc., and Helena Laboratories, Inc. The coagulation testing with high accuracy and specificity is expected to remain a major factor in the global Special coagulation testing market.
Special Coagulation Test Market: Segmentation
The global Special coagulation test market is segmented on the basis of test type, product type, technology, end user and geography.
Based on test type, the global Special coagulation test market is segmented as:
- Prothrombin Time (PT)
- Activated Clotting Time (ACT)
- D Dimer
- Anti-factor Xa
- Activated Partial Thromboplastin Time (PTT)
- Heparin & Protamine Dose Response Test for ACT
- Platelet Function
- Other Coagulation Tests
Based on product type, the global Special coagulation test market is segmented as:
- Standards, Controls and Calibrations
- Automated Systems
- Semi-automated Systems
- Manual Systems
Based on technology type, the global Special coagulation test market is segmented as:
- Other Technologies
Based on end user, the global Special coagulation test market is segmented as:
- Clinical Laboratories
- Diagnostic Laboratories
- Home Care Settings
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years
Future Market Insights
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers, Dubai
United Arab Emirates